Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Warner-Lambert discloses complement C1r protease inhibitors

June 14, 1996

Polypeptides with neuroprotective/neurotrophic activity

June 14, 1996

Cephalon research reveals active compounds

June 14, 1996

RPR's riluzole approved in Europe

June 14, 1996

Myotrophin still pending full marketing approval

June 14, 1996

Lithium/nimodipine combination as bipolar I manic disorder treatment

June 14, 1996

Drug candidate for schizophrenia awaits clinical trials

June 14, 1996

Lilly reports metabotropic glutamate receptor antagonists

June 14, 1996

SmithKline Beecham describes 5-HT1D antagonists

June 14, 1996

Compounds with melatonin receptor affinity from Takeda

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...